ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

IVX Innosis Ecological Ag

0.00
0.00 (0.00%)
- - Realtime Data
Share Name Share Symbol Market Type
Innosis Ecological Ag TG:IVX Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

Directorate Change

22/04/2003 8:00am

UK Regulatory


     
BW20030421002004  20030422T060040Z UTC


( BW)(IVAX-CORPORATION)(IVX) Directorate Change

    Business Editors
    UK REGULATORY NEWS

    MIAMI--(BUSINESS WIRE)--April 22, 2003--

          IVAX Nominates 2003 Directors; Includes Three New 
                      Independent Directors
 
IVAX Corporation (AMEX:IVX)(LSE:IVX.L) announced today the nominees to
its board of directors for elections to be held at the 2003 annual
meeting of shareholders. The slate includes eight incumbent directors
and three additional independent directors.

The incumbent directors nominated are: Phillip Frost, M.D., Neil
Flanzraich, Jane Hsiao, Ph.D., Mark Andrews, Ernst Biekert, Ph.D.,
Jack Fishman, Ph.D., Richard Pfenniger, Jr. and David Lieberman.

The three additional independent director nominees are:

Betty G. Amos, CPA, is the owner and president of The Abkey Companies,
a franchisee of Fuddruckers restaurants. Ms. Amos holds both Bachelor
and Masters of Business Administration degrees from the University of
Miami and has served on the University of Miami board of trustees
since 1997, including two years as Chair of the audit committee. In
1993, The National Association of Women Business Owners recognized her
as their Outstanding Woman Business Owner.

Modesto A. (Mitch) Maidique, Ph.D., is the President of Florida
International University. During his 17-year tenure at FIU, Dr.
Maidique has presided over the establishment of the Schools of
Architecture, Computer Science, Music and Law, more than doubling
FIU's enrollment to over 34,000 students. Dr. Maidique holds a Ph.D.
from the Massachusetts Institute of Technology, is a graduate of the
Harvard Business School, and has taught at MIT, Harvard and Stanford
Universities. He serves on the boards of National Semiconductor and
Carnival Corporations and is a past chairman of The Beacon Council,
Miami's economic development authority.

Bertram Pitt, M.D. has been a Professor of Internal Medicine at the
University of Michigan School of Medicine since 1977, where he also
served as the Director of the Division of Cardiology from 1977 to 1991
and as Associate Chairman for Academic and Industrial Programs from
1991 to 1999. Dr. Pitt was elected to the Johns Hopkins University
Society of Scholars in 2000, received the Forest Dewey Dodrill Award
for Excellence from the American Heart Association in 2001 and the
Paul Dekruif Lifetime Achievement Award from the University of
Michigan in 2002.

IVAX also announced that Isaac Kaye will not stand for re-election to
the IVAX board and at the conclusion of the company's 2003 annual
meeting will retire as IVAX' Deputy Chief Executive Officer and Chief
Executive Officer of the UK division, positions he has held since
1990. Charles M. Fernandez will also not stand for re-election to the
board in order to devote more time to new business ventures. Mr.
Fernandez has served as a director since 1998.

Phillip Frost, M.D., chairman and chief executive officer of IVAX
said, "The board of directors has accepted Mr. Kaye's decision to
retire after a long and distinguished career at IVAX. The board of
directors and the entire IVAX community thank Mr. Kaye for his many
years of dedicated leadership in the company. Charles Fernandez is
also departing from our board; he has served us well. We are all
grateful for their many contributions."

Frank Condella, who joined IVAX last August as Managing Director in
the UK, will continue to direct IVAX' activities there, as well as
oversee other European operations.

IVAX Corporation, headquartered in Miami, Florida, discovers,
develops, manufactures, and markets branded and brand equivalent
(generic) pharmaceuticals and veterinary products in the U.S. and
internationally.

Copies of this and other news releases may be obtained free of charge
from IVAX' website at http://www.ivax.com.

   Short Name: IVAX Corporation
   Category Code: BOA
   Sequence Number: 00004141
   Time of Receipt (offset from UTC): 20030418T220231+0100

    --30--CK/ny*

    CONTACT: IVAX Corporation
             Jim Whitlow, 305/575-6043

    KEYWORD: FLORIDA UNITED KINGDOM INTERNATIONAL EUROPE
    INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL MANAGEMENT CHANGES
    SOURCE: IVAX Corporation

Today's News On The Net - Business Wire's full file on the Internet
                          with Hyperlinks to your home page.
                          URL: http://www.businesswire.com





1 Year Innosis Ecological Chart

1 Year Innosis Ecological Chart

1 Month Innosis Ecological Chart

1 Month Innosis Ecological Chart

Your Recent History

Delayed Upgrade Clock